U.S. Hot Rolled Coil Steel Market Size, Share, Trends, Industry Analysis Report By Thickness (Less Than or Equal to 3mm, Greater Than 3mm), by End Use – Market Forecast, 2025–2034

The U.S. hot rolled coil steel market size is expected to reach USD 42.65 billion by 2034, according to a new study by Polaris Market Research. The report “U.S. Hot Rolled Coil Steel Market Size, Share, Trends, Industry Analysis Report By Thickness (Less Than or Equal to 3mm, Greater Than 3mm), by End Use – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The U.S. hot rolled coil steel market encompasses the production and trade of steel that has been shaped by passing it through rollers at very high temperatures. This process, occurring above the steel's recrystallization point, makes the material easier to form and work with, resulting in a coiled product. Hot rolled coil steel is a foundational material due to its strength, durability, and cost-effectiveness, making it indispensable across a wide range of industrial applications.

The U.S. hot rolled coil steel market growth is driven by robust activities in sectors such as construction and infrastructure, where steel is vital for structural components, and the automotive industry, which uses it for vehicle frames and parts. The market's potential is also influenced by government initiatives promoting domestic manufacturing and infrastructure spending. Industry trends also reflect a push toward technological developments in steelmaking processes and a focus on sustainable production methods.

U.S. Hot Rolled Coil Steel Market Report Highlights:

By thickness, the greater than 3mm segment held a larger share in 2024. It is heavily used in demanding applications such as large-scale construction, heavy machinery, and certain automotive components, where its superior strength and durability are crucial for structural integrity and bearing heavy loads.

By end use, the construction and infrastructure segment held the largest share in 2024. This dominance is driven by the continuous demand for steel in building new residential and commercial properties, as well as extensive government and private investments in crucial infrastructure projects such as bridges, roads, and public utility networks across the country.

A few key players in the market include Nucor Corporation, Cleveland-Cliffs Inc., United States Steel Corporation (U.S. Steel), Steel Dynamics, Inc. (SDI), Commercial Metals Company (CMC), JSW Steel USA Inc., and California Steel Industries, Inc. (CSI).

Polaris Market Research has segmented the U.S. hot rolled coil steel market report on the basis of thickness and end use:

By Thickness Outlook (Revenue – USD Billion, 2020–2034)

Less Than or Equal to 3mm

Greater Than 3mm

By End Use Outlook (Revenue – USD Billion, 2020–2034)

Construction & Infrastructure

Oil & Gas/Energy

Automotive

Industrial Equipment

Shipbuilding & Marine

Others


1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Source
3.2.1. Primary Source
3.2.2. Secondary Source
4. U.S. DNA Manufacturing Market Insights
4.1. U.S. DNA Manufacturing Market – Market Snapshot
4.2. U.S. DNA Manufacturing Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Increasing demand for gene therapies
4.2.1.2. Rising demand for personalized medicine
4.2.2. Restraints and Challenges
4.2.2.1. Strict Regulation Norms
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. U.S. DNA Manufacturing Market Trends
4.6. Value Chain Analysis
5. U.S. DNA Manufacturing Market, by Type
5.1. Key Findings
5.2. Introduction
5.2.1. U.S. DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
5.3. Plasmid DNA
5.3.1. U.S. DNA Manufacturing Market, by Plasmid DNA, by Region, 2020-2034 (USD Billion)
5.4. Synthetic DNA
5.4.1. U.S. DNA Manufacturing Market, by Synthetic DNA, by Region, 2020-2034 (USD Billion)
5.4.2. Gene Synthesis
5.4.2.1. U.S. DNA Manufacturing Market, by Gene Synthesis, by Region, 2020-2034 (USD Billion)
5.4.3. Oligonucleotide Synthesis
5.4.3.1. U.S. DNA Manufacturing Market, by Oligonucleotide Synthesis, by Region, 2020-2034 (USD Billion)
6. U.S. DNA Manufacturing Market, by Grade
6.1. Key Findings
6.2. Introduction
6.2.1. U.S. DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
6.3. GMP Grade
6.3.1. U.S. DNA Manufacturing Market, by GMP Grade, by Region, 2020-2034 (USD Billion)
6.4. R&D Grade
6.4.1. U.S. DNA Manufacturing Market, by R&D Grade, by Region, 2020-2034 (USD Billion)
7. U.S. DNA Manufacturing Market, by Application
7.1. Key Findings
7.2. Introduction
7.2.1. U.S. DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
7.3. Cell & Gene Therapy
7.3.1. U.S. DNA Manufacturing Market, by Cell & Gene Therapy, by Region, 2020-2034 (USD Billion)
7.4. Vaccines
7.4.1. U.S. DNA Manufacturing Market, by Vaccines, by Region, 2020-2034 (USD Billion)
7.5. Oligonucleotide-based drugs
7.5.1. U.S. DNA Manufacturing Market, by Oligonucleotide-based drugs, by Region, 2020-2034 (USD Billion)
7.6. Others
7.6.1. U.S. DNA Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)
8. U.S. DNA Manufacturing Market, by End Use
8.1. Key Findings
8.2. Introduction
8.2.1. U.S. DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
8.3. Pharmaceutical and Biotechnology Companies
8.3.1. U.S. DNA Manufacturing Market, by Pharmaceutical and Biotechnology Companies, by Region, 2020-2034 (USD Billion)
8.4. Academic & Research Institutes
8.4.1. U.S. DNA Manufacturing Market, by Academic & Research Institutes, by Region, 2020-2034 (USD Billion)
8.5. Contract Research Organizations
8.5.1. U.S. DNA Manufacturing Market, by Contract Research Organizations, by Region, 2020-2034 (USD Billion)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. AGC Biologics
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Bionova Scientific
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. Catalent
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Charles River Laboratories
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. Danaher
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Eurofins Genomics
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. GenScript
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Lonza
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Thermo Fisher Scientific
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Twist Bioscience
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
10.11. VGXI, Inc.
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings